Table 3.
Multivariate Analysis of Risk Factors for Time to Progression of ALI
| Risk Factor | Relative Difference (hours) | 95% CI | P Value |
|---|---|---|---|
| Age | 1.5 | 0.2–2.7 | .02 |
| Sepsis | −46 | −89–−3 | .03 |
| Female gender | 19 | −19–57 | .32 |
| Race | |||
| Caucasian | 0 | ||
| Asian | −28 | −79–23 | .28 |
| Black | 5 | −64–75 | .88 |
| Other | −42 | −124–39 | .30 |
| Alcohol usea | 31 | −10–73 | .14 |
| Blood transfusionsb | −5 | −47–38 | .82 |
| Chronic diseasec | 17 | −22–57 | .39 |
| Positive cultured | −21 | −60–18 | .28 |
| Smoker (current) | −33 | −83–18 | .20 |
| Smoker (former) | −44 | −98–10 | .11 |
Abbreviations: ALI, acute lung injury; CI, confidence interval; APACHE II, Acute Physiology And Chronic Health Evaluation II.
Reported alcohol consumption greater than or equal to 1 drink per day.
Transfusion of blood products, including red blood cells, platelets, or fresh frozen plasma, within 72 hours prior to diagnosis of ALI.
As defined in the APACHE II scoring system, the presence of liver cirrhosis, congestive heart failure (New York Heart Association class IV), chronic hemodialysis, or severe immunosuppression.
Any positive microbiologic culture from any source taken within 72 hours prior to diagnosis of ALI.